Endometriosis Awareness Week 2020

It is the Endometriosis Awareness Week, and as GCT initiates a new study in the indication, we are glad to see that this condition receives more and more attention with each year, and it is an honor to contribute to raising awareness.

The condition of endometriosis occurs in women when the cells similar to the tissue normally covering the inside of the uterus, grow outside of it. While the causes remain unknown, the symptoms often include pelvic pain, heavy menstrual bleeding and pain while urinating. However, the absence of obvious symptoms is also common. Thus, medical imaging and tissue biopsy are usually necessary to diagnose this condition. While a few treatment options are available to ease the symptoms, many pharmaceutical companies are currently looking to develop new innovative and more effective medical products.

Though, the condition is invisible, it affects 1 in 10 women and causes them to suffer from pain daily. It can also lead to infertility. Worse yet, the diagnosis of the disease often takes 5+ years, as it is often confused with many other conditions.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.